Lujing Zhan Selected Research

Janus Kinases

7/2020

Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lujing Zhan Research Topics

Disease

3	Hypothermia 10/2017 - 01/2015
2	Rheumatoid Arthritis 01/2021 - 07/2020
2	Arthralgia (Joint Pain) 01/2021 - 07/2020
1	Fatigue 01/2021
1	Pain (Aches) 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Infections 07/2020
1	Overweight 01/2015
1	Obesity 01/2015

Drug/Important Bio-Agent (IBA)

2	baricitinibIBA 01/2021 - 07/2020
2	ametantrone (HAQ)IBA 01/2021 - 07/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2020
1	C-Reactive ProteinIBA 07/2020
1	Janus KinasesIBA 07/2020

Therapy/Procedure

3	General Anesthesia 10/2017 - 01/2015
2	Therapeutics 01/2021 - 07/2020
2	Anesthesia 01/2017 - 01/2015